: Multigenic panels in breast cancer: clinical utility and management of patients with pathogenic variants other than BRCA1/2
: This paper evaluates the clinical management and utility of testing for genetic mutations beyond the standard BRCA1/2 genes in breast cancer patients. It addresses how multigene panels help identify additional risks and guide treatment decisions, such as the use of PARP inhibitors. Other Possible Interpretations 10443_1.txt
: Critical Reviews in Oncology/Hematology (Volume 201, 2024, Article 104431). : Multigenic panels in breast cancer: clinical utility
The query likely refers to a scholarly article identified by its digital or database index. Based on recent academic listings, is the article ID for a specific medical study published in Critical Reviews in Oncology/Hematology . Article Details 10443_1.txt